Background. The Perma-Flow prosthetic coronary graft is a 5-mm polytet
rafluoroethylene tube into which is incorporated a Venturi flow restri
ctor. An aorto-superior vena caval fistula is created and coronary ana
stomoses are constructed proximal to the resistor in side-to-side fash
ion, where arterial pressure is maintained. From November 1992 through
December 1995, eight investigational centers in North America have im
planted this graft in 40 patients with inadequate autologous alternati
ves. Methods. Patients were selected for inclusion in this study if co
ronary artery bypass grafting was required and adequate autologous con
duit to complete revascularization was not available. Operative data w
ere completed by the implantating surgeon and referred to a central ce
nter, the Minneapolis Heart Institute, for correlation. Follow-up was
conducted by data coordinators at each institution, and follow-up data
were obtained directly from these coordinators for inclusion in the s
tudy. Results. Patient age ranged from 53 to 82 years, and 15 patients
were undergoing reoperations (38%). On each Perma-Flow graft one to f
our coronary side-to-side anastomoses were constructed. In addition, l
eft internal mammary artery (n = 26), greater saphenous vein (8), righ
t internal mammary artery (4), and gastroepiploic artery (4) were used
to complete revascularization. Aortic (2) or mitral valve replacement
(1) was also carried out. There were seven operative deaths (18%) and
two late deaths (4 and 6 months). After 1 to 37 months (mean, 13 +/-
9 months) of follow-up, 29 of 31 surviving patients are asymptomatic.
Echocardiographic heart size has not increased from the postoperative
value, indicating limited volume load has not affected heart size. Pro
tocol catheterization (n = 32) in 28 patients 1 week to 1 year postope
ratively revealed 7 of 73 studied coronary anastomoses (9.5%) and two
distal extensions and resistors were occluded (7%). In 1 patient durin
g sternal debridement at 1 year, no flow was found in the graft. Concl
usions. The Perma-Flow graft is a useful adjunct to complete revascula
rization in patients with deficient autologous conduit.